Retatrutide, from Soma Corp., is receiving increasing attention as a innovative treatment for weight regulation. This dual-action medication combines the mechanism of a GLP-1 receptor stimulant and a GIP receptor agonist , intended to not only promote reduced body fat but also improve associated